MV BioTherapeutics presented at the 7th Microbiome Movement – Drug Development Europe

Fabio Grassi (MV BioTherapeutics founder) has been invited to contribute to the 7^th Microbiome Movement – Drug Development Summit Europe 2023 being held in London during January 31^st-February 2^nd, 2023.

The presentation has been included in the second day of the conference at 14.00.

Reprogramming the Microbiome in Cancer Immunotherapy

• Outlining the adaptive modulation of the microbiota in dysbiosis by apyrase mediated secretory IgA amplification
• Exploring gut ecosystem proficiency in cancer immunotherapy by oral administration of apyrase